The effect of systemic antibiotics administered during the active phase of non-surgical periodontal therapy or after the healing phase: a systematic review by FRITOLI, Aretuza et al.
J Appl Oral Sci. 249 2015;23(3):249-54
ABSTRACT
www.scielo.br/jaos
http://dx.doi.org/10.1590/1678-775720140453
The effect of systemic antibiotics administered 
during the active phase of non-surgical periodontal 
therapy or after the healing phase: a systematic 
review
Aretuza FRITOLI, Cristiane GONÇALVES, Marcelo FAVERI, Luciene Cristina FIGUEIREDO, Paula Juliana PÉREZ-
CHAPARRO, Daiane FERMIANO, Magda FERES
Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.
Corresponding address: Magda Feres - Centro de Pós-Graduação e Pesquisa - CEPPE - Universidade Guarulhos - Praça Tereza Cristina, 229 - Centro - 
07023-070 - Guarulhos - SP - Brazil - Phone  +55 11 2087 3594 - e-mail: mferes@ung.br
Submitted: November 4, 2014 - Modification: January 23, 2015 - Accepted: March 2, 2015
Objective: The aim of this systematic review was to compare the clinical effectiveness of systemic antibiotics administered in the active stage of periodontal treatment or 
after the healing phase. Material and Methods: An electronic search was performed in the 
databases EMBASE, MEDLINE and Cochrane Central Register of Controlled Trials (CENTRAL), 
in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis 
(PRISMA) statement. A manual search of the reference list of selected studies and of 
review articles was also performed up to November 2013. Randomized Clinical Trials (RCT) 
that evaluated the systemic administration of antibiotics as adjuvants to scaling and root 
planning (SRP) at different phases of periodontal treatment were included. Systematic 
reviews and studies that evaluated subjects with systemic diseases and those that used 
subantimicrobial doses of antibiotics were excluded. Results: The initial search identified 
1,039 articles, of which seven were selected, and only one met the inclusion criteria. This 
study showed that subjects taking metronidazole and amoxicillin at the initial phase of 
treatment exhibited statistically significantly greater reduction in pocket depth and gain in 
clinical attachment level in initially deep sites (PD≥7 mm) than subjects taking antibiotics 
after healing (p<0.05). This comparison was conducted 2 months after antibiotic intake, 
at the healing phase. Conclusion: To date, only one short-term RCT has directly compared 
different moments of systemic antibiotics administration, as adjuncts to SRP, in the 
treatment of periodontitis. Although the results of this study suggested some benefits for 
antibiotics intake during the active phase of therapy, these findings need to be confirmed 
by larger placebo-controlled randomized clinical trials with longer follow-up periods.
Keywords: Periodontal diseases. Chronic periodontitis. Aggressive periodontitis. Therapy. 
Antibiotics.
INTRODUCTION
Periodontal diseases are infectious-inflammatory 
conditions that may lead to the loss of teeth. Scaling 
and root planing (SRP) is the most commonly 
therapy used for the treatment of periodontitis. 
Although SRP promotes an improvement in the 
clinical periodontal parameters in the majority of 
cases, it is frequently insufficient to change the 
bacterial profile associated with periodontitis to 
a profile compatible with periodontal health, i.e., 
with lower levels and proportions of periodontal 
pathogens and higher proportions of beneficial 
microorganisms, such as the Actinomyces species4. 
Therefore, the clinical beneficial results achieved 
with this procedure in the short-term are frequently 
not maintained in the long term, particularly in more 
advanced cases6,22 or in those associated with risk 
factors, such as smoking16 and diabetic patients19. 
These individuals normally respond less favorably 
to mechanical treatments, either because of the 
impaired host response as in the case of smokers, 
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or due to the higher severity of disease observed in 
patients with diabetes mellitus3,13. For this reason, 
other treatments, such as the administration 
of systemic antibiotics have been proposed in 
association with SRP, with the goal of potentiating 
the effects of this therapy.
In spite of the clinical relevance and effective use 
of systemic antibiotics in the treatment of various 
infectious diseases, clinical studies on the effects 
of these agents in the treatment of periodontal 
diseases only began in the 1970s25. Over the course 
of the last few decades, antibiotics have been widely 
studied as adjuvants to mechanical periodontal 
therapy and several clinical studies have shown 
additional benefits with the use of these agents5,10,12. 
However, it is important to highlight that antibiotics 
are biologically active substances that can lead 
to side effects of various intensities and their 
indiscriminate use might lead to the increase in the 
pool of bacterial species tolerant to the antibiotics4. 
In the light of this knowledge, it is important to 
highlight that the decision of whether or not to use 
these agents to treat periodontitis should follow 
the same principle used for the treatment of any 
other infection in the body, which is: the risks need 
to be clearly offset by benefits to the patient. The 
only way to determine this risk/benefit ratio is by 
evaluating the results of well-conducted randomized 
clinical trials (RCTs).
Recent RCTs and systematic reviews have 
suggested that the combination of metronidazole 
(MTZ) and amoxicillin (AMX) are effective for the 
treatment of aggressive periodontitis17,18,24 and 
chronic periodontitis2,6,8,23,29. However, although a 
notable therapeutic advantage has been shown 
when MTZ+AMX are used in periodontal therapy, 
some questions relative to the protocol for the 
use of these medications remain obscure, such 
as: “which would be the best phase of the non-
surgical periodontal therapy treatment for the 
administration of antibiotics?”.
In clinical practice, the decision to use antibiotics 
is commonly taken after the healing phase of the 
mechanical treatment, which may vary from 2 to 5 
months9 post-SRP. However, some biologic concepts 
suggest that the effects of antibiotics could be 
potentiated if they were used during the active 
phase of treatment5. Apparently, a rapid and more 
profound reduction of the subgingival microbial 
load may lead to a more beneficial recolonization 
of the recently scaled pockets in the long term. 
Lighter and sequential disturbances of the biofilm 
may not be sufficient to change the highly stable 
climax community of biofilm26,27. Therefore, since 
there is no consensus in the literature about the 
ideal time for the administration of these agents, a 
systematic review of the literature could help with 
taking the correct clinical decision and could guide 
future studies on this topic.
MATERIAL AND METHODS
This systematic review was conducted in 
accordance with the recommendations of PRISMA 
(Preferred Reporting Items for Systematic Reviews 
and Meta-analysis)20.
Focused question
“At which phase of non-surgical periodontal 
therapy would systemic antibiotics promote the 
best clinical results, including reduction in probing 
depth (PD) and gain in clinical attachment level 
(CAL): during the active phase or after the healing 
phase of mechanical therapy?”
Inclusion criteria
In order to be included in the sample, the papers 
had to be: RCTs with at least two groups, one test 
(systemic antibiotic used in the active phase of 
mechanical treatment) and one control (systemic 
antibiotic used after the healing phase of the 
mechanical therapy) group; studies that included 
individuals with chronic or aggressive periodontitis; 
and studies that evaluated PD and CAL.
Terms used Number of 
studies
periodontitis OR periodontal infection OR chronic periodontitis OR aggressive 
periodontitis OR periodontal disease
79,029
And “periodontal disease” OR “periodontitis” OR “alveolar bone loss” OR “oral conditions” 
OR “tooth diseases” OR "anti-bacterial agents" OR "anti-bacterial"  OR "anti-bacterial 
agents" OR "antibiotics" OR "anti-bacterial agents" AND "OR "anti-infective agents" 
OR"anti-infective" AND "agents" OR "anti-infective agents" OR "antimicrobials" OR 
"anti-infective agents" AND "OR "systemic AND "anti-infective agents" OR "anti-
infective" AND "agents" OR "anti-infective agents" OR "antimicrobials" OR "anti-
infective agents" AND "OR "AND systemic AND "anti-infective agents" OR "anti-
infective" AND "agents" OR "anti-infective agents" OR "antimicrobial”
1,039
Figure 1- Descriptors, free terms and key words used in the search strategy
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Exclusion criteria
Studies published in languages other than 
Portuguese, English and Spanish, reviews of the 
literature, and studies that used antibiotics in 
subantimicrobial doses were excluded from the 
sample.
Evaluation variables
Changes in full-mouth mean PD and CAL, as 
well as changes in mean PD and CAL in different 
categories of pockets.
Search strategy
The EMBASE, MEDLINE and Cochrane Central 
Register of Controlled Trials (CENTRAL) were 
searched up to November 2013 by two researchers 
(ARFS e CG), using the search strategy described 
in Figure 1. A manual search of the reference list 
of selected studies and of review articles about the 
topic was also performed. Studies were selected 
by the two researchers in an independent manner, 
and any disagreement was resolved by a third 
researcher (MFe).
Data extraction
Studies that fulfilled the inclusion and exclusion 
criteria were submitted to data extraction by one 
of the researchers (ARFS). The following items of 
Figure 2- Flow chart of the search strategy
Study Study
Design
Sample Intervention Follow-up Results Conclusion
Griffiths, 
et al.9 
(2011)
RCT Group A
n=20         
5 
smokers 
16 
females 
GAgP
Group A
FMRSD+AMX 
500 mg+MTZ 
500 mg (TID 
for 7 days) 
starting right 
after the 
completion 
of SRP+CHX 
0.2% for two 
weeks
                                   
8 months after 
SRP (2 months 
post-antibiotic 
intake in Group 
B)
                                                    
Group A: showed greater 
reduction in mean PD 
and gain in CAL in initially 
deep sites (with PD≥7 mm) 
than Group B. Difference 
between groups of 0.9 mm 
(PD reduction) and 0.7 mm 
(CAL gain) (p<0.05). 
                                                    
Subjects who received 
MTZ+AMX at the 
initial therapy showed 
statistically  significant 
additional benefits 
compared with those 
who received the same 
antibiotic  regimen after 
the healing phase.
Group B 
n=21       
4 
smokers 
12 
females 
GAgP
Group B
FMRSD+AMX 
500 mg+MTZ 
500 mg (TID 
for 7 days) 
starting 6 
months after 
the completion 
of SRP+CHX 
0.2% for two 
weeks
The percentage of sites 
converting from PD≥5 
mm to ≤4 mm was 83% in 
Group A and 67% in Group 
B (p=0.041)
RCT: randomized clinical trial; GAgP: generalized aggressive periodontitis; FMRSD: full mouth root surface debridement; 
AMX: amoxicillin; MTZ: metronidazole; TID: three times a day; SRP: scaling and root planning; PD: probing depth; CAL: 
clinical attachment level; CHX: chlorhexidine
Figure 3- Description of the analyzed study 
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information were collected and recorded on a piloted 
form: 1) place where the research was conducted 
– country and environment in which the patients 
were treated (private clinic or hospital/university 
clinics); 2) randomization method; 3) sample 
characteristics – sample size, age, gender, local and 
systemic health conditions, characteristics of the 
interventions performed, statistical significance; 4) 
clinical results; 5) conflict of interest; 6) funding.
RESULTS
The flow diagram of this study is represented in 
Figure 2. In the electronic search, 1039 studies were 
identified. After reading the titles and abstracts, 
1032 studies were excluded, and 7 were selected. 
No article was identified in the manual search. 
After reading the full text of the 7 selected studies, 
6 were excluded1,2,11,15,21,28 because they did not 
directly compare the moment of administration 
of the systemic antibiotics in the treatment of 
periodontitis. Therefore, only 1 study9 was included 
in this review. In this study, the authors compared 
the clinical efficacy of MTZ+AMX administered in 
the active phase of periodontal treatment, i.e., 
together with the SRP procedure (initial antibiotic 
therapy – Group A, n=20) or after the healing 
phase, i.e., 6 months after the completion of the 
SRP (antibiotic after healing – Group B, n=21). All 
subjects received periodontal maintenance scaling 
at 6 months. Clinical parameters were registered 
at 2 months after the treatment of Group B with 
antibiotics (i.e., 8 months after treatment of group 
A/Baseline). The data showed that subjects taking 
antibiotics at the initial phase of treatment exhibited 
statistically significant greater reduction in pocket 
depth and gain in clinical attachment level in 
initially deep sites (PD≥7 mm) than subjects taking 
antibiotics at re-assessment (difference between 
groups of 0.9 mm and 0.7 mm, respectively). In 
addition, the percentage of sites converting from 
PD≥5 mm to ≤4 mm was 83% in Group A and 67% 
in Group B (p=0.041) (Figure 3).
DISCUSSION
The results of this systematic review 
demonstrated that up until today, only one study 
in the literature compared the effects of systemic 
antibiotics administered in different phases of 
mechanical therapy. This study, published by 
Griffiths, et al.9 (2011), suggested there were 
greater clinical benefits when MTZ+AMX were 
prescribed during the active phase of periodontal 
therapy than after the healing phase. Individuals 
treated with antibiotics together with SRP in the 
initial phase of treatment, showed greater reduction 
in PD and greater gain in CAL in deep pockets than 
individuals treated with antibiotics 6 months after 
SRP. It is worth pointing out that this study presents 
some limitations, for example, the fact of not having 
used placebo and having had a short longitudinal 
evaluation time (the comparison between the two 
groups was conducted at 2 months post-antibiotic 
intake at the healing phase). The use of placebo 
allows blinding of the study, which is one of the 
criteria that define the high quality of a RCT20. 
In addition, a longer follow-up period would be 
important in order to establish whether or not these 
results would be maintained over the course of time.
Apart from the study included in this review, 
Kaner, et al.14 (2007) conducted a retrospective 
evaluation of individuals with generalized aggressive 
periodontitis treated with SRP+MTZ+AMX 
administered immediately or 3 months after 
mechanical treatment, and observed that the time 
of administration of the antibiotics influenced the 
clinical response. Three months after the second 
group had taken the antibiotics, the group treated 
in the active phase of therapy obtained statistically 
significantly higher reductions in the mean PD (4.09 
mm) and relative gain in CAL (2.50 mm) in deep 
sites (with PD>6 mm) in comparison with the group 
that took MTZ+AMX at the time of re-evaluation 
(2.80 mm and 1.41 mm, respectively) (p<0.05).
The results of the studies of Griffiths, et al.9 
(2011) and Kaner, et al.14 (2007) suggest a benefit 
for the administration of MTZ+AMX in the active 
phase of mechanical treatment. These results 
suggest that the systemic antibiotics administered 
together with the mechanical treatment in the 
initial phase of therapy has a greater potential to 
change the pathogenic bacterial community to a 
community compatible with periodontal health in 
the short term. This statement is in agreement with 
the concept that a rapid and striking reduction in the 
subgingival microbiota would be necessary in order 
to obtain more beneficial and stable recolonization 
over time in the recently scaled pockets26,27. The 
biofilm structure, especially the mature biofilm 
found in the subgingival pockets of individuals 
with periodontitis, presents resilience, meaning 
that they tend to go back to their original structure 
(i.e., a composition observed in disease, with high 
proportions of pathogens and low proportions of 
beneficial species). Therefore, intense treatments 
applied at once, such as the association of SRP and 
antibiotics during the initial therapy, might have 
greater potential to create an entirely new and 
stable biofilm community, similar to that observed 
in healthy individuals5. In addition, a hypothesis 
related to the high degree of inflammation observed 
in non-treated periodontal patients may also help 
to explain the greater clinical benefit observed in 
the individuals who took antibiotics in the initial 
phase of treatment7,14. In the presence of an 
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intense inflammatory process, there are higher 
levels of gingival fluid; therefore, higher levels of 
antibiotic are also released into the subgingival 
environment7,14. In addition, inflammation is also 
associated with great capillary permeability, which 
may contribute to better absorption of these 
agents7,14.
Implications for research and clinical 
practice
In daily clinical practice, periodontists tend to 
postpone the administration of antibiotics to the re-
assessment phase, rather than as part of the initial 
treatment. An evidence-based appraisal of current 
literature presented in this manuscript showed 
that, to date, only one short-term RCT has directly 
compared different moments of systemic antibiotics 
administration as adjuncts to SRP in the treatment 
of periodontitis. Although the results of this study 
suggested some benefits for antibiotics intake 
during the active phase of therapy, these findings 
need to be confirmed by larger placebo-controlled 
randomized clinical trials with longer follow-up 
periods. This information could help clinicians with 
their decision-making in the daily practice.
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